Beta-adrenergic agonists.
Boyle
J G
JG
Ohio State University Medical Center, Columbus, USA.
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007752:Obstetric Labor, Premature / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D011247:Pregnancy; D013726:Terbutaline / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D015149:Tocolytic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration
D000318:Adrenergic beta-Agonists; D015149:Tocolytic Agents; D013726:Terbutaline